Hypercoagulability and thrombosis in COVID-19: a modifiable cause for mortality?
Eur Heart J
.
2021 Aug 31;42(33):3143-3145.
doi: 10.1093/eurheartj/ehab417.
Authors
Noel Chan
1
,
John Eikelboom
1
Affiliation
1
Population Health Research Institute, Hamilton, Ontario, Canada and Hamilton General Hospital and McMaster University, Hamilton, Ontario, Canada.
PMID:
34254136
PMCID:
PMC8344546
DOI:
10.1093/eurheartj/ehab417
No abstract available
Publication types
Comment
MeSH terms
COVID-19*
Humans
SARS-CoV-2
Thrombophilia* / complications
Thrombosis* / etiology